Suppr超能文献

既往乳腺钼靶筛查对台湾地区乳腺癌检测效能的影响。

The Effects of Prior Mammography Screening on the Performance of Breast Cancer Detection in Taiwan.

作者信息

Chang Chin-Chuan, Ho Tzu-Chuan, Lien Chih-Ying, Shen Daniel Hueng-Yuan, Chuang Kuo-Pin, Chan Hung-Pin, Yang Ming-Hui, Tyan Yu-Chang

机构信息

Department of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.

School of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

出版信息

Healthcare (Basel). 2022 Jun 2;10(6):1037. doi: 10.3390/healthcare10061037.

Abstract

The aim of this study was to investigate the influence of previous mammography screening on the performance of breast cancer detection. The screened women were divided into first-visit and follow-up groups for breast cancer screening. The positive predictive value (PPV), cancer detection rate (CDR), and recall rate were used to evaluate and analyze the overall screening performance among the two groups. Among them, 10,040 screenings (67.2%) were first visits and 4895 screenings (32.8%) were follow-up visits. The proportion of positive screening results for first-visit participants was higher than that for their follow-up counterparts (9.3% vs. 4.0%). A total of 98 participants (74 first-visit and 24 follow-up visit) were confirmed to have breast cancer. The PPV for positive mammography for women who underwent biopsy confirmation was 28.7% overall, reaching 35.8% for the follow-up visit group and 27.0% for the first-visit group. The CDR was 6.6 per 1000 overall, reaching 7.4 per 1000 for first-visit group and 4.9 per 1000 for the follow-up group. The overall recall rate was 7.9%, reaching 9.7% for the first-visit group and 4.2% for the follow-up group. The PPV is improved and the recall rate is decreased if prior mammography images are available for comparison when conducting mammography screening for breast cancer. By this study, we concluded that prior mammography plays an important role for breast cancer screening, while follow-up mammography may increase the diagnostic rate when compared to the prior mammography. We suggest that the public health authority can encourage subjects to undergo screenings in the same health institute where they regularly visit.

摘要

本研究旨在调查既往乳腺钼靶筛查对乳腺癌检测性能的影响。接受筛查的女性被分为乳腺癌筛查首次就诊组和随访组。采用阳性预测值(PPV)、癌症检测率(CDR)和召回率来评估和分析两组的总体筛查性能。其中,10040次筛查(67.2%)为首次就诊,4895次筛查(32.8%)为随访。首次就诊参与者的阳性筛查结果比例高于随访参与者(9.3%对4.0%)。共有98名参与者(74名首次就诊和24名随访)被确诊患有乳腺癌。接受活检确诊的女性乳腺钼靶阳性的PPV总体为28.7%,随访组为35.8%,首次就诊组为27.0%。CDR总体为每1000人6.6例,首次就诊组为每1000人7.4例,随访组为每1000人4.9例。总体召回率为7.9%,首次就诊组为9.7%,随访组为4.2%。在进行乳腺癌钼靶筛查时,如果有既往钼靶图像可供比较,则PPV会提高,召回率会降低。通过本研究,我们得出结论,既往钼靶筛查对乳腺癌筛查起着重要作用,而与既往钼靶筛查相比,随访钼靶筛查可能会提高诊断率。我们建议公共卫生当局鼓励受试者在其定期就诊的同一健康机构接受筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60e/9223050/9c9ad240836e/healthcare-10-01037-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验